Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. (MLND) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MLND · as of Jun 9, 2026
Key Statistics
Explore Millendo Therapeutics, Inc. Data
mlnd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
Competitors & Peers
mlnd competitorsMLND
AMTI
CYCC
GLS
HURA
KRROStock Performance
Full HistoryAbout Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therap…
what is millendo therapeutics, inc. · mlnd stock overview · millendo therapeutics, inc. company profile · who is millendo therapeutics, inc. ceo · mlnd NASDAQ · millendo therapeutics, inc. headquarters · millendo therapeutics, inc. business segments
About Stock Overview & Key Data
Millendo Therapeutics, Inc. (MLND) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 4, 2012. As of the latest trading session, MLND stock price is $1.06, with a market capitalization of $11.1M. The stock has returned -65.25% over the past 12 months and +0.00% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Millendo Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Millendo Therapeutics, Inc. reported revenue of — and net income of -$26.3M. For detailed data — including Millendo Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Millendo Therapeutics, Inc. (MLND) stock price is $1.06. The stock is traded on NASDAQ under the ticker symbol MLND. The 52-week range is $1.06 – $1.13.